Sulfamethoxazole

磺胺甲噁唑

Report date: 2023/02/23 17:54:28
NME

Base Information

Drug NameSulfamethoxazole
Drug Alias Namesulfamethoxazolum新明磺sulfametoxazol磺胺甲基异唑磺胺甲基恶唑 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydropteroate synthase inhibitors
TargetsDihydropteroate synthase
Therapy Area/IndicationsUrinary Tract InfectionsBacterial Infections
Global Approved IndicationsUrinary Tract InfectionsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1965/07/01
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu First Pharmaceutical Co Ltd
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsBacterial Infections
Inactive IndicationsUrinary Tract Infections

Other Information

ATC CodeJ01EC01
Related LinksWikipediaDrugBankKEGG